Sabitlenmiş Tweet
The endTB-Q clinical trial results represent a major advancement in the treatment of pre-XDR-TB. Read more here 👉bit.ly/endTBQresults
@MSFsci @PIH @IRDGlobal @UNITAID #TB
English
endTB
341 posts
endTB
@endTB
@PIH, @MSF & @IRDglobal. A new partnership to change MDR-TB treatments around the world.
17 countries Katılım Haziran 2014
163 Takip Edilen1.8K Takipçiler
Important conclusions transpire from the results of the endTB-Q clinical trial. Read more here >> bit.ly/endTBQresults
@MSFsci @PIH @IRDGlobal @UNITAID #TB #UnionConf
English
MAJOR NEWS: the endTB-Q clinical trial results are in! They were just presented at the #UnionConf, in Bali. Read the full press release here>>bit.ly/endTBQresults
@MSFsci @PIH @IRDGlobal @UNITAID
English
The endTB-Q clinical trial results represent a major advancement in the treatment of pre-XDR-TB. Read more here 👉bit.ly/endTBQresults
@MSFsci @PIH @IRDGlobal @UNITAID #TB
English
Reminder: the presentation of the endTB-Q clinical trial results is happening tomorrow at the #UnionConf in Bali! More here👉bit.ly/endTB-Q. And stay tuned for details about the results of this groundbreaking trial!
@MSFsci @PIH @IRDGlobal @UNITAID
English
📢The results of the endTB-Q clinical trial, which assesses the safety and efficacy of a new and shorter regimen for the treatment of pre-XDR-TB, will be presented for the first time at the #UnionConf in Bali on Nov 13.👉bit.ly/endTB-Q
@MSFsci @PIH @IRDGlobal @UNITAID
English
📢 Breaking news: in a rapid communication, the WHO recommended 3 new, shorter, more tolerable regimens for MDR/RR-TB, which were studied in the endTB clinical trial! More details 👉bit.ly/4fUAsPS
@MSFsci @PIH @IRDGlobal @UNITAID
English
The endTB consortium partners are happy to report that the last visit for the last study participant in the endTB-Q trial was completed on 22 July! Read more: bit.ly/3Sm1oy0
@MSFsci @PIH @IRDGlobal @UNITAID
English
🌟Join us on May 23, for #EpicentreScientificDay! Maelenn Gouillou, Biostatistician of the endTB project, will present findings on drug-resistant tuberculosis subgroups from the #endTB clinical trial.
Don't miss it at 2:15pm at Salons de l'Aveyron in Paris.
More info here👇🏾
Epicentre_MSF@Epicentre_MSF
📢 D-1 month before the Scientific Day! Ready to dive in? TB experts will be on hand to discuss DIAGNOSIS and TREATMENT, highlighting the challenges and solutions for the most vulnerable populations, in particular, children! Registration 👉🏾 epicentre.msf.org/en/scientific-…
English
🌟 Exciting news! Today at #ESCMIDGlobal2024, Dr. Lorenzo Guglielmetti, Director of the #endTB project, will be presenting a groundbreaking comparison of efficacy and safety between experimental regimens for MDR-TB from the endTB clinical trial (Hall H, 13:30-15:30).
ESCMID@ESCMID
Ready for day 4 of #ESCMIDGlobal2024? While it is the final day, the fun is not over yet. We have plenty of symposiums, sessions and talks lined up. Whether you're joining onsite or remotely, tell us what is on your agenda today? Thank you for you the incredible turnout!
English
endTB retweetledi
The @EndTB trial results increase patient-centred treatment options for RR/MDR-TB with three shortened, all-oral, noninferior regimens to a current well-performing standard of care. #MSFSciDaysSA2024
More details 👉msfsa.me/3vZYMh9
MSF Science@MSFsci
Check out this interesting session on "Improving treatment of multidrug-resistant #TB" by Dr Kunda K. Mikanda at #MSFSciDay. He talks about the results from the endTB clinical trial Exciting opportunity to listen👉 bit.ly/3U07J1Z
English
Save the date! 🚀
The MSF Scientific Days Southern Africa 2024 are starting tomorrow, Wed. April 17.
We thank Dr. Kunda Mikanda, Principal Investigator of the endTB Clinical Trials site in Lesotho, who will present the results of the trial on improving the treatment of MDR-TB.
Head Of Mission - Djoki Bahati@MSF_EswatiniHoM
The MSF in Eswatini team is eagerly looking forward to the forthcoming MSF Scientific Days Southern Africa 2024 event, scheduled for April 17, 2024. This full-day event will be an opportunity for us to disseminate knowledge on various topics such as sexual health, tuberculosis,
English
endTB retweetledi
Joining hands for #WTBDay 2024, the endTB trial community met at IRD’s Community Dissemination Event.
They celebrated their contribution in advancing knowledge for the treatment of MDR-TB.
@PIH @MSF @UNITAID
#irdglobal #tuberculosis
1/2.
English
On this #WorldTBDay24 , join #endTB in celebrating last year’s achievements in the fight against multidrug-resistant #tuberculosis.
Check out our latest news and results: endtb.org/news-stories and endtb.org/endtb-clinical…
@MSF_france @IRDGlobal @PIH @UNITAID @UCSF
English
endTB retweetledi
.@IRDGlobal @MSF @PIH , and funder @UNITAID would like thank all those who attended the endTB clinical trial results presentations at the #UnionConf this week! Safe travels home and stay tuned!
English
Join us today at 6pm CET at the #UnionConf Community Connect session where researchers will share the #endTB trial results with communities! @MSFsci @IRDGlobal @PIH @UNITAID
English
@MSF @PIH @IRDGlobal @UNITAID The #endTB trial found 3 new drug regimens delivering similar efficacy & safety to conventional treatments while reducing treatment time by up to two-thirds.
The trial also adds a 4th regimen as an alternative for people who cannot tolerate some TB drugs. bit.ly/46a1n4g
English
.@MSF @PIH @IRDGlobal, and funder @UNITAID are proud to announce that the endTB trial results are out! This landmark trial offers multiple new shortened, all-oral drug regimens to treat adults and children with #MDRTB. Read our press release and more here: bit.ly/3FXSOir
English